Effects of T-cadherin expression on B16F10 melanoma cells

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1205-1210

  Duan, Xin Suo ^a   Lu, Jie ^a   Ge, Zhi Hua ^a   Xing, En Hong ^a   Lu, Hai Tao ^a   Sun, Li Xin ^a  

^a CHENGDE MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Invasiveness; Melanoma; Proliferation; T cadherin

Indexed keywords

COMPLEMENTARY DNA; LIPOCORTIN 5; PROPIDIUM IODIDE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE PHASE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MELANOMA B16; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; T CADHERIN GENE; TUMOR GROWTH;

EID: 84874400767     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1164     Document Type: Article

References (49)

1. Erdei E and Torres SM: A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther 10: 1811-1823, 2010.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
3. Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al: A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88: 1484-1491, 2000.
4. Houghton AN and Polsky D: Focus on melanoma. Cancer Cell 2: 275-278, 2002.
5. Wheelock MJ and Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19: 207-235, 2003.
6. van Roy F and Berx G: The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788, 2008.
7. Takeichi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811, 1993.
8. Christofori G and Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76, 1999.
9. Ranscht B and Dours-Zimmermann MT: T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 7: 391-402, 1991.
10. Andreeva AV and Kutuzov MA: Cadherin 13 in cancer. Genes Chromosomes Cancer 49: 775-790, 2010.
11. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P and Resink TJ: A guide and guard: the many faces of T-cadherin. Cell Signal 21: 1035-1044, 2009.
12. Kuphal S, Martyn AC, Pedley J, Crowther LM, Bonazzi VF, Parsons PG, et al: H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res 22: 296-306, 2009.
13. Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y and Furihata M: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 583: 430-436, 2009.
14. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, et al: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61: 8659-8663, 2001.
15. Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI and Shridhar V: Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 15: 715-720, 1999.
16. Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, et al: Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene 25: 2636-2645, 2006.
17. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, et al: Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61: 4556-4560, 2001.
18. Sato M, Mori Y, Sakurada A, Fujimura S and Horii A: The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103: 96-101, 1998.
19. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al: DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 358: 1118-1128, 2008.
20. Zhong Y, Delgado Y, Gomez J, Lee SW and Perez-Soler R: Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin Cancer Res 7: 1683-1687, 2001.
21. Lee SW, Reimer CL, Campbell DB, Cheresh P, Duda RB and Kocher O: H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 19: 1157-1159, 1998.
22. Chan DW, Lee JM, Chan PC and Ng IO: Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer 123: 1043-1052, 2008.
23. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XF, et al: Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. J Drug Target 20: 582-592, 2012.
24. Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, et al: Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol 108: 149-154, 2011.
25. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, et al: Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol 63: 725-735, 2011.
26. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Song YX, et al: Stronger cytotoxicity in CTLs with granzyme B and porforin was induced by Ganoderma lucidum polysaccharides acting on B16F10 cells. Biomed Prev Nutr 2: 113-118, 2012.
27. Hufbauer M, Lazić D, Reinartz M, Akgül B, Pfister H and Weissenborn SJ: Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. J Dermatol Sci 64: 7-15, 2011.
28. Liang Y and Sundberg JP: SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes. J Dermatol Sci 63: 148-153, 2011.
29. Lai WW, Hsiao YP, Chung JG, Wei YH, Cheng YW and Yang JH: Synergistic phototoxic effects of glycolic acid in a human kerati-nocyte cell line (HaCaT). J Dermatol Sci 64: 191-198, 2011.
30. Chang SP, Shen SC, Lee WR, Yang LL and Chen YC: Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells. J Dermatol Sci 62: 183-191, 2011.
31. Dong D, Jiang M, Xu X, Guan M, Wu J, Chen Q and Xiang L: The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro. J Dermatol Sci 66: 20-28, 2012.
32. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
33. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278, 2001.
34. Wheelock MJ, Soler AP and Knudsen KA: Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 6: 275-285, 2001.
35. Goodwin M and Yap AS: Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton. J Mol Histol 35: 839-844, 2004.
36. Drees F, Pokutta S, Yamada S, Nelson WJ and Weis WI: Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 123: 903-915, 2005.
37. Doyle DD, Goings GE, Upshaw-Earley J, Page E, Ranscht B and Palfrey HC: T-cadherin is a major glycophos-phoinositol-anchored protein associated with noncaveolar detergent-insoluble domains of the cardiac sarcolemma. J Biol Chem 273: 6937-6943, 1998.
38. Koller E and Ranscht B: Differential targeting of T- and N-cadherin in polarized epithelial cells. J Biol Chem 271: 30061-30067, 1996.
39. Philippova M, Ivanov D, Tkachuk V, Erne P and Resink TJ: Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro: a function in vascular cell motility? Histochem Cell Biol 120: 353-360, 2003.
40. Kinch MS, Petch L, Zhong C and Burridge K: E-cadherin engagement stimulates tyrosine phosphorylation. Cell Adhes Commun 4: 425-437, 1997.
41. Philippova MP, Bochkov VN, Stambolsky DV, Tkachuk VA and Resink TJ: T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett 429: 207-210, 1998.
42. Vestal DJ and Ranscht B: Glycosyl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J Cell Biol 119: 451-461, 1992.
43. Dames SA, Bang E, Haüssinger D, Ahrens T, Engel J and Grzesiek S: Insights into the low adhesive capacity of human T-cadherin from the NMR structure of Its N-terminal extracellular domain. J Biol Chem 283: 23485-23495, 2008.
44. Takeuchi T and Ohtsuki Y: Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 16: 1287-1293, 2001.
45. Joshi MB, Philippova M, Ivanov D, Allenspach R, Erne P and Resink TJ: T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. FASEB J 19: 1737-1739, 2005.
46. Fredette BJ, Miller J and Ranscht B. Inhibition of motor axon growth by T-cadherin substrata. Development 122: 3163-3171, 1996.
47. Rubina K, Sysoeva V, Semina E, Kalinina N, Yurlova E, Khlebnikova A and Molochkov V: Malignant transformation in skin is associated with the loss of T-cadherin expression in human keratinocytes and heterogeneity in T-cadherin expression in tumor vasculature. In: Tumor Angiogenesis. Ran S (ed). InTech, New York, NY, pp135-166, 2012.
48. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2: 776-782, 1996.
49. Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, et al: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62: 3382-3386, 2002.